A Study of Adjuvant Melanoma Stakeholder Treatment Preferences

A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery

NCT03843593 ·Status: COMPLETED

Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma

NCT01709162 ·Status: TERMINATED ·Phase: PHASE2

Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States

NCT03199846 ·Status: COMPLETED

Treatment Use Study for Advanced Melanoma.

NCT00584493 ·Status: NO_LONGER_AVAILABLE

Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.

NCT00057616 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma

NCT04099251 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma

NCT00636168 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor

NCT00796445 ·Status: TERMINATED ·Phase: PHASE3

Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database

NCT05426239 ·Status: COMPLETED

Neoadjuvant and Adjuvant Checkpoint Blockade

NCT02519322 ·Status: COMPLETED ·Phase: PHASE2

Investigating Participation Patterns Among Stage IV Melanoma Patients

NCT06093594 ·Status: NOT_YET_RECRUITING

Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma

NCT00707161 ·Status: TERMINATED ·Phase: PHASE2

Real-world Outcomes Among Patients With Melanoma Treated With Neoadjuvant Nivolumab+Relatlimab or Nivolumab+Ipilimumab

NCT07091695 ·Status: COMPLETED

Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

NCT06295159 ·Status: RECRUITING ·Phase: PHASE2

Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United Kingdom

NCT03448497 ·Status: COMPLETED

Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma

NCT05527795 ·Status: RECRUITING

A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma

NCT04708418 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma

NCT01531244 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

NCT05572463 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

CP-461 in the Treatment of Patients With Advanced Melanoma

NCT00060710 ·Status: TERMINATED ·Phase: PHASE2

Observational Study of Nivolumab Monotherapy or in Combination With Ipilimumab in Participants With Advanced Melanoma and in Participants With Adjuvant Nivolumab Therapy

NCT02990611 ·Status: COMPLETED

Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma

NCT03504696 ·Status: COMPLETED

Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants

NCT04495010 ·Status: WITHDRAWN ·Phase: PHASE2

A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma

NCT01654692 ·Status: COMPLETED ·Phase: PHASE2

Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS

NCT05180942 ·Status: RECRUITING